Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients

Strasser E, Steininger P, Korn K, Achenbach S, Tenbusch M, Cunningham S, Zimmermann R, Überla K, Hackstein H (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Abstract

Background The frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia in blood donors is uncertain. Thus, assays for SARS-CoV-2 RNA detection in blood, validated on commercially available polymerase chain reaction (PCR) systems, are required to allow a good comparability of data.

Authors with CRIS profile

Erwin Strasser Medizinische Fakultät Philipp Steininger Institute of Clinical and Molecular Virology Klaus Korn Institute of Clinical and Molecular Virology Susanne Achenbach Department of Transfusion Medicine and Haemostaseology Matthias Tenbusch Professur für Genbasierte Immunisierungsverfahren Sarah Cunningham Department of Transfusion Medicine and Haemostaseology Robert Zimmermann Medizinische Fakultät Klaus Überla Lehrstuhl für Klinische und Molekulare Virologie Holger Hackstein Professur für Transfusionsmedizin und Cell-Engineering

How to cite

APA:

Strasser, E., Steininger, P., Korn, K., Achenbach, S., Tenbusch, M., Cunningham, S.,... Hackstein, H. (2020). Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients. Transfusion. https://doi.org/10.1111/trf.16178

MLA:

Strasser, Erwin, et al. "Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients." Transfusion (2020).

BibTeX: Download